USD 0.98
(-4.85%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 592.84 Thousand CAD | 22.27% |
2022 | 484.85 Thousand CAD | -57.12% |
2021 | 1.13 Million CAD | 301.11% |
2020 | 281.87 Thousand CAD | 0.0% |
2019 | - CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
2014 | - CAD | 0.0% |
2013 | - CAD | 0.0% |
2012 | - CAD | 0.0% |
2011 | - CAD | 0.0% |
2010 | - CAD | 0.0% |
2009 | - CAD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 130.53 Thousand CAD | -49.62% |
2023 Q4 | 592.84 Thousand CAD | -21.96% |
2023 Q3 | 759.63 Thousand CAD | 13.25% |
2023 FY | 592.84 Thousand CAD | 22.27% |
2023 Q1 | 843.29 Thousand CAD | 73.93% |
2023 Q2 | 670.78 Thousand CAD | -20.46% |
2022 Q2 | 550.76 Thousand CAD | -34.69% |
2022 Q3 | 253.42 Thousand CAD | -53.99% |
2022 FY | 484.85 Thousand CAD | -57.12% |
2022 Q4 | 484.85 Thousand CAD | 91.32% |
2022 Q1 | 843.29 Thousand CAD | -25.41% |
2021 Q1 | 247.35 Thousand CAD | -12.24% |
2021 Q3 | 172.81 Thousand CAD | -18.12% |
2021 Q4 | 1.13 Million CAD | 554.25% |
2021 Q2 | 211.06 Thousand CAD | -14.67% |
2021 FY | 1.13 Million CAD | 301.11% |
2020 Q3 | 304.3 Thousand CAD | 0.0% |
2020 Q1 | - CAD | 0.0% |
2020 FY | 281.87 Thousand CAD | 0.0% |
2020 Q4 | 281.87 Thousand CAD | -7.37% |
2020 Q2 | - CAD | 0.0% |
2019 Q3 | - CAD | 0.0% |
2019 Q4 | - CAD | 0.0% |
2019 FY | - CAD | 0.0% |
2019 Q1 | - CAD | 0.0% |
2019 Q2 | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2018 Q1 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q4 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
2015 Q1 | - CAD | 0.0% |
2014 Q1 | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2014 Q4 | - CAD | 0.0% |
2014 FY | - CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2013 Q4 | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2012 Q4 | - CAD | 0.0% |
2012 Q3 | - CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
2011 Q3 | - CAD | 0.0% |
2011 Q4 | - CAD | 0.0% |
2011 FY | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2011 Q2 | - CAD | 0.0% |
2010 Q3 | - CAD | 0.0% |
2010 FY | - CAD | 0.0% |
2010 Q4 | - CAD | 0.0% |
2009 Q4 | - CAD | 0.0% |
2009 FY | - CAD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Akoya Biosciences, Inc. | 75.25 Million USD | 99.212% |
AngioDynamics, Inc. | 3.93 Million USD | 84.949% |
AtriCure, Inc. | 60.59 Million USD | 99.022% |
Avinger, Inc. | - USD | -Infinity% |
Azenta, Inc. | 60.43 Million USD | 99.019% |
BioLife Solutions, Inc. | 18.31 Million USD | 96.762% |
The Cooper Companies, Inc. | 2.52 Billion USD | 99.977% |
Daxor Corporation | 755.65 Thousand USD | 21.546% |
Ekso Bionics Holdings, Inc. | 4.83 Million USD | 87.731% |
Femasys Inc. | 4.25 Million USD | 86.078% |
GlucoTrack, Inc. | 196 Thousand USD | -202.47% |
Harvard Bioscience, Inc. | 30.7 Million USD | 98.069% |
Hologic, Inc. | 2.49 Billion USD | 99.976% |
ICU Medical, Inc. | 1.57 Billion USD | 99.962% |
Intuitive Surgical, Inc. | -82.1 Million USD | 100.722% |
KORU Medical Systems, Inc. | 3.65 Million USD | 83.771% |
LeMaitre Vascular, Inc. | 16.62 Million USD | 96.434% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Innovative Eyewear, Inc. | - USD | -Infinity% |
Masimo Corporation | 871.7 Million USD | 99.932% |
Microbot Medical Inc. | 40 Thousand USD | -1382.103% |
Meihua International Medical Technologies Co., Ltd. | 4592.00 USD | -12810.301% |
Merit Medical Systems, Inc. | 823.01 Million USD | 99.928% |
Nephros, Inc. | 1.39 Million USD | 57.35% |
NovoCure Limited | 596.24 Million USD | 99.901% |
NEXGEL, Inc. | 513 Thousand USD | -15.564% |
NEXGEL, Inc. | 513 Thousand USD | -15.564% |
Singular Genomics Systems, Inc. | 67.52 Million USD | 99.122% |
OraSure Technologies, Inc. | 11.38 Million USD | 94.794% |
Pro-Dex, Inc. | 7.53 Million USD | 92.133% |
Pulse Biosciences, Inc. | 8.08 Million USD | 92.668% |
Predictive Oncology Inc. | 2.18 Million USD | 72.917% |
Precision Optics Corporation, Inc. | 1.93 Million USD | 69.409% |
QuidelOrtho Corporation | 2.27 Billion USD | 99.974% |
Repligen Corporation | 510.14 Million USD | 99.884% |
Sanara MedTech Inc. | 9.11 Million USD | 93.495% |
STAAR Surgical Company | 31.46 Million USD | 98.116% |
Sharps Technology, Inc. | - USD | -Infinity% |
Utah Medical Products, Inc. | 295 Thousand USD | -100.963% |
DENTSPLY SIRONA Inc. | 1.79 Billion USD | 99.967% |
Jin Medical International Ltd. | - USD | -Infinity% |